Gene Salkind, Director at Coeptis Therapeutics Holdings, Inc. (COEP), bought 32,644 shares at $1.01 ($30K) on 2023-08-29, disclosed to the SEC on 2023-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 28,638 | $26K | 86.6% |
| 2 | $1.01 | 4,006 | $4K | 13.4% |
| Total | $0.92 avg | 32,644 | $30K | 100% |
| Filing → |
| UPXI | BUY | 2025-07-30 | $200K | — | Filing → |
| UPXI | BUY | 2025-04-25 | $1.1M | — | Filing → |
| COEP | BUY | 2024-01-09 | $8K | — | Filing → |